- Home
- CDNA vs ROOT Comparison
CDNA vs ROOT Comparison
Compare CDNA & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- ROOT
- Stock Information
- Founded
- CDNA 1998
- ROOT 2015
- Country
- CDNA United States
- ROOT United States
- Employees
- CDNA N/A
- ROOT N/A
- Industry
- CDNA Medical Specialities
- ROOT Property-Casualty Insurers
- Sector
- CDNA Health Care
- ROOT Finance
- Exchange
- CDNA Nasdaq
- ROOT Nasdaq
- Market Cap
- CDNA 712.2M
- ROOT 2.3B
- IPO Year
- CDNA 2014
- ROOT 2020
- Fundamental
- Price
- CDNA $13.94
- ROOT $100.40
- Analyst Decision
- CDNA Buy
- ROOT Buy
- Analyst Count
- CDNA 8
- ROOT 6
- Target Price
- CDNA $26.86
- ROOT $130.60
- AVG Volume (30 Days)
- CDNA 1.4M
- ROOT 444.0K
- Earning Date
- CDNA 11-03-2025
- ROOT 10-29-2025
- Dividend Yield
- CDNA N/A
- ROOT N/A
- EPS Growth
- CDNA N/A
- ROOT N/A
- EPS
- CDNA 1.00
- ROOT 4.73
- Revenue
- CDNA $340,826,000.00
- ROOT $1,364,700,000.00
- Revenue This Year
- CDNA $13.02
- ROOT $27.41
- Revenue Next Year
- CDNA $12.85
- ROOT $9.74
- P/E Ratio
- CDNA $13.99
- ROOT $21.15
- Revenue Growth
- CDNA 14.72
- ROOT 59.76
- 52 Week Low
- CDNA $10.96
- ROOT $36.87
- 52 Week High
- CDNA $32.97
- ROOT $181.14
- Technical
- Relative Strength Index (RSI)
- CDNA 55.98
- ROOT 53.50
- Support Level
- CDNA $13.23
- ROOT $94.64
- Resistance Level
- CDNA $13.80
- ROOT $102.47
- Average True Range (ATR)
- CDNA 0.68
- ROOT 4.11
- MACD
- CDNA 0.17
- ROOT 2.14
- Stochastic Oscillator
- CDNA 85.79
- ROOT 86.21
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.